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Mucus is a protective gel that lines respiratory tract surfaces. To
identify potential roles for secreted gel–forming mucins in lung
development, we isolated murine lungs on embryonic days (E) 12.5–
18.5, and postnatal days (PN) days 5, 14, and 28. We measured the
mucin gene expression by quantitative RT-PCR, and localization by
histochemical and immunohistochemical labeling. Alcian blue/peri-
odic acid–Schiff–positive cells are present from E15.5 through PN28.
Muc5b transcripts were abundant at all time points from E14.5 to
PN28. By contrast, transcript levels of Muc5ac and Muc2 were
approximately 300 and 85,000 times lower, respectively. These data
are supported by immunohistochemical studies demonstrating the
production and localization of Muc5ac and Muc5b protein. This
study indicates that mucin production is prominent in developing
murine lungs and that Muc5b is an early, abundant, and persistent
marker of bronchial airway secretory cells, thereby implicating it
as an intrinsic component of homeostatic mucosal defense in
the lungs.
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At approximately 4 weeks of gestation in humans (embryonic
days 9.0–9.5 in mice), tracheal and lung-bud formation initiates
as a pocket of endoderm evaginates from the ventral floor of
the embryonic foregut and invades the underlying mesoderm.
The developing lungs undergo repeated branching steps, giving
rise to the complex of tubes that form the conducting airways
and alveolar saccules. During this process of branching and mor-
phogenesis, the endoderm changes from an undifferentiated
mass to a pseudostratified squamous layer, and then to a differ-
entiated layer comprised of heterogeneous progenitor and ma-
ture cells (1).
Mature respiratory epithelial cells possess many unique
functions that can be attributed to their structural features or
their secretory products. Structural features such as the long,
apical projections of tracheobronchial ciliated cells and the thin
sheet-like squamous morphologies of alveolar Type I cells are
examples of obvious morphological traits that are specifically
linked to cellular function (ciliary clearance and gas exchange,
respectively). Secreted products also demarcate the functions of
individual respiratory epithelial subtypes. The tracheobronchial
epithelium produces secreted products, such as mucins, that serve
defensive functions by preventing the accumulation of particles
and pathogens in the distal lung (2–4), whereas Type II pneumo-
cytes produce surfactant lipids that reduce surface tension and
prevent alveolar collapse, thereby permitting effective gas ex-
change (5). Additional anatomically selective markers include
the secretaglobin (Scgb) family, with members such as Scgb1a1
(or Clara cell secretory protein) in the airways, and surfactant
proteins A, B, and C in the alveoli. The expression of many of
these markers is low early during lung development, when the
bronchial epithelium is poorly differentiated, and becomes more
abundant as epithelial maturation occurs late in embryonic
gestation and throughout postnatal life (6).
The importance of mucins as defensive molecules in adult
airways is suggested by their abundance during homeostasis and
their up-regulation during inflammation. We previously showed
that Muc5b is the predominant secreted gel-forming mucin
expressed in healthy adult murine lungs (7, 8), whereas Muc5ac
is the most predominantly induced gel-forming mucin in allergic
murine lungs (7). To determine whether the baseline expression
patterns of Muc5ac and Muc5b reflect secretory cell differentiation




C57BL6/J mice were purchased from Jackson Laboratory (Bar Harbor,
ME). Mice were housed in accordance with the Institutional Animal
Care and Use Committee of the M.D. Anderson Cancer Center. To
initiate timed pregnancies, mice were mated for a single night. Females
manifesting a vaginal plug were separated and housed in isolation for an
additional 9–20 days. At specific postcoital times (days 10–18), some
females were killed, and their fetuses were isolated surgically. Three to
eight pups were collected at various time points for histological and
expression analyses.
Histological Preparation
Because of their small size, whole embryos from embryonic days (E) 10.5
to E16.5 were fixed in 10% neutral buffered formalin. For samples isolated
from E17.5 to postnatal day (PN) 28, lungs were isolated and inflated with
formalin. Tissues were dehydrated, paraffin-embedded, and cut into 5-mm
sections that were collected on positively charged slides and stored for
subsequent histochemical and immunohistochemical staining.
CLINICAL RELEVANCE
The lungs are exposed to millions of particles and potential
pathogens daily from early life to adulthood. Mucus is an
intrinsic defensive component in the airways that acts as
a barrier to inhaled materials. This study provides impor-
tant insights into the composition of mucin glycoprotein
and the timing of its production in murine lungs.
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Histochemistry and Immunohistochemistry
Dewaxed and rehydrated tissue sections were stained histochemically
using alcian blue/periodic acid–Schiff (AB-PAS), as described pre-
viously (9), to detect acidic sulfated mucins (AB), O-glycosides (PAS),
and sialic acid (PAS). AB-PAS is not mucin-specific, because it also
labels glycosaminoglycan and other polysaccharide moieties. Thus, for
the immunolocalization of Muc5ac, tissues were exposed to an anti-
mouse Muc5ac peptide chicken polyclonal antibody (1:2,000) at room
temperature for 1 hour (10). For Muc5b, tissues were incubated with
a polyclonal rabbit anti-mouse Muc5b peptide antibody (1:10,000) at
room temperature for 1 hour (8). Specific staining for both antibodies
was confirmed by comparing experimental samples with preimmune
and immune sera–treated adult lung, stomach, and sublingual gland
samples (data not shown). After washing, biotinylated secondary
antibodies, followed by a horseradish peroxidase (HRP)–streptavidin
binding complex (Vector Laboratories, Burlingame, CA), were then
applied. HRP reactions were visualized using 3–39 diaminobenzadine.
Nuclei were counterstained with methyl green. Slides were imaged
using an Olympus DP-71 CCD camera, mounted on an Olympus BX-
60 upright microscope (Olympus America, Center Valley, PA).
RNA Isolation and Quantitative RT-PCR
To measure the expression of specific mucin transcripts and Scgb1a1,
quantitative PCR was performed on reverse-transcribed total RNA
isolated from lungs (E17.5–PN28) or microdissected thoraces (E14.5–
E16.5). Isolated tissues were placed in a Petri dish, and minced in 1 ml
Trizol reagent (Invitrogen, Carlsbad, CA). Total RNA was isolated
according to the manufacturer’s instructions. Complementary DNA was
synthesized using Superscript III Reverse Transcriptase (Invitrogen),
with random 9-mer oligonucleotide primers (Sigma, St. Louis, MO).
Volumes of cDNA reaction mix, corresponding to an initial total RNA
input mass of 100 ng, were amplified using gene-specific fluorescein
amidate/Black Hole Quencher (FAM/BHQ)–labeled fluorescent re-
porter probes, as reported previously for the gel-forming mucins Muc2,
Muc5ac, Muc5b, and Muc19 (7). The expression patterns of Scgb1a1 and
of the membrane-associated mucins Muc1, Muc4, and Muc16 were also
examined. Primer and probe sequences are listed in Table E1 in the online
supplement. Data were normalized to g-actin expression levels, and
differences were compared by ANOVA, with a P-value cutoff of 0.05.
RESULTS
Detection of Mucin-Producing Cells in the Lungs during
Embryonic and Postnatal Development
Cells containing apical AB-PAS–stained materials that were
morphologically indicative of mucous cells were detectable in
developing murine lungs from E15.5 through PN28 (Figure 1).
They were present predominantly in the cartilaginous (extrap-
ulmonary) and axial (intrapulmonary) bronchial airways, and
they were rare in the bronchioles from E15.5 onward (Table E2).
These data suggest that a mucous phenotype is present at baseline
in developing murine lungs. Interestingly, although AB-PAS–
positive cells are rare in the bronchi before E15.5, they are
abundant in the developing bronchioles and alveolar saccules.
The AB-PAS staining seen in these distal regions is distributed
among basal and apical intracellular compartments, and is most
likely attributable to the high concentrations of glycogen within
developing acini (11). Thus, given that histochemical stains such
as AB-PAS identify numerous glycosylated macromolecules and
are not specific for mucins per se, we tested for changes in the
production of respiratory mucin, using specific transcript and
protein probes.
Muc5ac and Muc5b mRNAs Are Expressed in the Developing
Murine Lung
Mucin transcripts were analyzed by quantitative RT-PCR (Fig-
ure 2 and Table E3). At the earliest time point studied, E14.5,
Muc5b transcripts were abundant (38 mol Muc5b mRNA/mol
g-actin mRNA). By contrast, Muc2 and Muc5ac transcripts were
1,471-fold and 1,992-fold less abundant, respectively. At PN14,
Muc5b remained the most abundant gel-forming mucin
expressed in the airways (44 mol Muc5b mRNA/mol g-actin
mRNA). The expression of Muc5ac increased 7.7-fold (0.15 mol
Muc5ac mRNA/mol g-actin mRNA), but this was not statistically
significant (P 5 0.21), and is still approximately 300 times lower
than the expression of Muc5b at this time point. Muc2 expression
decreased 4.7-fold at this time point to a barely detectable level.
Muc19 transcripts were undetectable at all time points in our
study (, 10 copies per reaction), consistent with previous findings
in adult mice (7, 12). For reference, expression of the airway
secretory cell marker Scgb1a1 was also analyzed. The expression
of Scgb1a1 was low at prenatal time points (0.14–1.6 mol Scgb1a1
mRNA/mol g-actin mRNA), but was rapidly and robustly in-
duced postnatally, increasing 6,138-fold to 16,072-fold from PN5
to PN28. At PN5, the expression of Scgb1a1 was approximately
15-fold higher than that of Muc5b (1,537 mol Scgb1a1 mRNA/
mol g-actin mRNA versus 102 mol Muc5b mRNA/mol g-actin
mRNA). Lastly, we measured the expression of the membrane-
associated mucins Muc1, Muc4, and Muc16. At the time points
examined here, all three were expressed, with Muc1 and Muc4
present at approximately 100-fold and approximately 1,000-fold
higher concentrations than Muc16, and approximately 10-fold
and approximately 100-fold lower concentrations than Muc5b,
respectively (Figure E1).
Muc5ac and Muc5b Proteins Are Expressed in the Developing
Murine Lung
Protein expression levels were tested immunohistochemically,
using antibodies specific for Muc5ac and Muc5b. Muc5b protein
was continuously produced by tracheobronchial epithelial cells
from E14.5–PN28, with a steady increase from E16.5–E18.5, after
which it remained abundantly detectable postnatally within
tracheobronchial surface epithelial cells (Figure 3). Muc5b was
highly enriched in cartilaginous airways from E15.5 onward. It
was also present in the intrapulmonary axial airways, although
often at significantly lower concentrations, and it was absent in
the bronchioles (Table E4). Muc5ac was also detectable during
murine lung development (Figure 4). In contrast to the persis-
tently strong and significantly more abundant immunolabeling
seen for Muc5b (Table E4), immunolabeling for Muc5ac in the
airways proved negative at all time points studied, except on
PN14 (Table E5).
DISCUSSION
This study demonstrates that murine airways express the gel-
forming mucins Muc5ac and Muc5b during prenatal and post-
natal development. In particular, Muc5b is abundantly expressed
at early embryonic time points, and continuously throughout lung
development (Figures 2 and 3). It remains abundant under
steady-state conditions in the adult, as we showed previously (7,
8). Thus, the production of Muc5b is an early, intrinsic, and
constitutive process in the airways. By contrast, although it is
markedly and selectively up-regulated during inflammation in
numerous models (2, 3), the expression of Muc5ac is much lower
at all time points studied here (Figure 2). These data suggest that
Muc5b is sufficient for the homeostatic functions of airway mucus,
whereas the expression of Muc5ac may take on greater impor-
tance under pathophysiological conditions.
Numerous studies from our group and others focused on the
association of the up-regulated production of mucin in disease
states such as asthma (13, 14), chronic obstructive pulmonary
disease (15–17), and cystic fibrosis (18–20), and in animal models
of these diseases (7, 21–26). In the present study, however, we
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focused on the production of airway mucins under nondiseased
conditions. The current dogma states that the intrapulmonary
airways of mice are lined by Clara cells but lack goblet/mucous
cells at baseline (the latter finding was based on traditional
staining techniques such as AB-PAS) (27). However, we found
that numerous cells do line murine airways, and produce mucin in
the baseline state (Figures 1 and 3). Our best explanations for the
differences between our findings and those in the literature are
twofold. First, the production of Muc5b at baseline occurs in
balance with its tonic rate of secretion, keeping intracellular
concentrations low. This is supported by its intracellular accu-
mulation at the histochemical level, without any change in its
expression at the mRNA level in secretion-deficient Munc13–2
knockout mice (8). Second, the routine AB-PAS chemical
labeling techniques have 100–1,000-fold lower sensitivity (28,
29) than those using antibody/lectin labeling followed by enzyme-
mediated detection approaches, similar to those used here (8, 29,
30). As such, this study confirms abundant Muc5b production in
adult mice (8, 31). Further, we demonstrate that Muc5b gene
expression occurs precociously in murine lungs, preceding even
that of the eponymous marker Clara cell secretory protein
(Scgb1a1).
The increased production of mucin in the intrapulmonary
airways of adult mice during mucous metaplasia localizes to
a subset of Scgb1a1-expressing secretory cells in the bronchial
(central) airways, but it is absent in Scgb1a1-expressing cells of
the bronchiolar (peripheral) airways (9). This phenomenon of
spatially restricted mucin production in adult mice is also present
in the baseline uninflamed state (8). In the present study, we
found that this was also the case in developing lungs in utero.
Thus, the specification program that determines the mucin-
producing potential of secretory cells in murine airways occurs
embryonically. In addition to Muc5ac and Muc5b, numerous
other conducting airway-specific genes demonstrate spatially and
temporally restricted gene expression patterns. These include
Scgb1a1 and the related secretaglobin genes Scgb3A1 and
Scgb3A2 (32), the adenosine A3 receptor (33), and the chitinases
(34). Notably, nascent Muc5b expression at E14.5 precedes that
of Scgb1a1 and its relatives at E16.5 and later (Figure 2) (32).
Given that discrete spatiotemporal gene regulatory programs are
activated at each step of lung development, understanding which
program functions at the initial time of airway secretory cell
differentiation could provide novel insights into the regulation of
secretory product synthesis in adult lungs.
In addition to the novel identification of mucin expression
patterns in embryonic murine lungs, our study also identified
a brief period of mucous metaplasia during postnatal develop-
ment. At PN14, the airway epithelium has a mucous phenotype,
similar to that seen in antigen-sensitized and antigen-challenged
Figure 1. Alcian blue/periodic acid–Schiff
(AB-PAS)–positive cells are prominent in
prenatal and postnatal developing murine
lungs. Tissue sections (5 mm) were removed
from whole embryos (E) and isolated lungs
of postnatal (PN) wild-type C57/BL6 mice
isolated at the indicated time points, and
stained with AB-PAS. Large arrows in low-
magnification images (top) identify airway
sites shown in high magnification (below).
Small arrows (below) identify positively stained
cells. Scale bar, 2 mm for low magnification,
and 30 mm for high magnification.
Figure 2. Quantitative RT-PCR analysis demonstrates the expression of
Muc5ac and Muc5b in the developing murine lung. Gene-specific
probes were used to measure concentrations of the mucins Muc2 (solid
circles), Muc5ac (solid squares), and Muc5b (solid triangles), and of
Clara cell secretory protein (Scgb1a1) (open circles), compared with
g-actin. Data represent means 6 standard errors (n 5 3–8 animals/time
point). Data were analyzed by ANOVA. P , 0.05 was considered
significant. **Identifies significance between concentrations of Muc5b
mRNA and those of Muc5ac and Muc2. †Identifies significance be-
tween Muc5ac and Muc2. ‡Identifies significance between embryonic
day (E) 14.5 and later values. Differences in concentrations of Muc5ac
and Muc2 were not significant over time. PN, postnatal day.
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mice with a prominent mucous phenotype and induction of
Muc5ac (9). This early postnatal phenomenon was also reported
by others, with allergic inflammatory (35, 36) and Foxa2 tran-
scription factor (35) regulatory pathways being strongly impli-
cated. Notably, our study is novel because it distinguished
between the abundance of Muc5ac, Muc5b, and other mucins.
At the protein level, Muc5ac was significantly increased at PN14,
whereas the production of Muc5b remained stable (Figures 3 and
4, and Tables E3 and E4). In our study, however, the 7.7-fold
increase in the detection of Muc5ac mRNA was not statistically
significant (Figure 2). This discordance is likely related to either
a missed point of transcriptional up-regulation at some discrete
time after PN5 and before PN14, or to the tonic activation of the
Muc5ac promoter at moderately low concentrations throughout
this period. Because this phenotype occurs during postnatal
alveologenesis, that is, a period of high cell proliferation and
alveolar multiplication in murine lungs (37–39), a persistently up-
regulated mucous phenotype may be induced to facilitate the
clearance of materials from peripheral compartments during
distal lung morphogenesis.
In humans, gel-forming mucins are also expressed during
lung development (40, 41). Although the gestational periods of
mice and humans differ greatly (3 weeks versus 40 weeks,
respectively), the phases of lung development are quite similar.
The embryonic, pseudoglandular, and canalicular phases occur
at 3–7, 5–17, and 16–26 weeks in humans, and on E9–E11.5,
Figure 3. Muc5b protein is constitutively
produced in prenatal and postnatal devel-
oping murine lungs. Immunostaining for
Muc5b was performed using polyclonal rab-
bit anti-mouse Muc5b antibody (1:10,000),
and detected with a peroxidase-conjugated
goat anti-rabbit antibody (1:200) and 3,39-
diaminobenzidine (DAB). Large arrows in
low-magnification images (top) identify air-
way sites shown in high magnification (be-
low). Small arrows (below) identify positively
stained cells. Scale bar, 2 mm for low mag-
nification, and 30 mm for high magnification.
Figure 4. Muc5ac protein is briefly pro-
duced in postnatal developing murine
lungs. Immunostaining for Muc5ac was per-
formed using polyclonal chicken anti-mouse
Muc5ac peptide chicken polyclonal anti-
body (1:2,000), and detected with a biotiny-
lated goat anti-chicken antibody (1:500)
and DAB. Large arrows in low-magnification
images (top) identify airway sites shown in
high magnification (below). Small arrows
(below) identify positively stained cells. Scale
bar, 2 mm for low magnification, and 30 mm
for high magnification.
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E11.5–E16.5, and E16.5–E17.5 in mice. The patterns of
MUC5AC/Muc5ac and MUC5B/Muc5b expression during
these stages correlate across species (MUC in humans/Muc in
mice). Before E14.5 in mice, the bronchial epithelium is a poorly
differentiated, pseudostratified layer, and very little Muc5ac or
Muc5b is evident. This is also the case for MUC5AC and
MUC5B expression in human embryos before 5 weeks of
gestational age. During the pseudoglandular and canalicular
phases of lung development, a transformation of the epithelium
to a cuboidal appearance occurs, coinciding with the increasing
expression of MUC5B/Muc5b in the bronchial submucosal
glands (humans) and the surface epithelium (humans and mice)
(40, 41) (Figure 3 and Table E3). Indeed, significant differences
are evident in the lungs of mice and humans, involving total
lung capacity (TLC), conducting airway volume relative to
TLC, the abundance and location of smooth muscle and
cartilage, and the expression and localization of secretory
products such as Scgb1a1. However, because mice lack intra-
pulmonary submucosal glands, the abundant expression of
Muc5b by surface cells is likely to substitute for homeostatic
functions that are supplied by Muc5b-rich submucosal gland
secretions in larger mammals and humans from development
onward. We thus propose that even in the presence of strong
differences in lung anatomy among species, the phenotypic
continuity of baseline MUC5B/Muc5b expression underlies an
important functional role for that expression in homeostatic
functions such as mucociliary clearance.
The expression of gel-forming mucins by the airway epithe-
lium is presumed to have an important function in regulating
lung health and disease. The 11p15 locus (where MUC5AC and
MUC5B lie) is linked to bronchial hyperreactivity in asthma
(42), and polymorphisms in the MUC5B promoter region were
linked to the development of diffuse panbronchiolitis (43) and
idiopathic interstitial pneumonias (44). Confirmation that these
variations are based on deleterious mutations will implicate
impaired homeostatic and pathophysiological mucous functions,
and in particular the importance of the gel-forming mucins
MUC5AC and MUC5B, in the development and prevention of
lung pathology. In addition to chronic lung diseases in which the
production of mucins may be etiological, diseases in which
airway mucin overproduction and mucous hypersecretion are
prominent in perinatal or early postnatal life, such as broncho-
pulmonary dysplasia and cystic fibrosis, may be affected by the
gestational production of airway mucins. Notably, childbirth can
result in the exposure of newborn infants to environmental
microbial agents such as group B streptococci (45). We specu-
late that the production of Muc5b is important in preventing
colonization and infection by these and other potential patho-
gens. However, in the absence of empirical tests of causality, the
assertion of essential roles for these respiratory mucins remains
hypothetical. Findings in Muc2 mutant mice serve as precedents
that provide strong support for a protective function of gel-
forming mucin in the intestinal tract. The loss or mutation of
Muc2, the sole gel-forming mucin produced in the colon at
baseline, causes persistent colitis and the development of
colorectal tumors in mice (46–48). Future studies investigating
the roles of the respiratory mucins Muc5ac and Muc5b may
demonstrate their significance in health and disease.
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